Misiu143,
Couldn't agree more.
Very disappointing about Amarex. I would suspect they would be creating an expensive liability by withholding patient data necessary for treatment.
Another reason why Dr Recknor type folk bring real value to CytoDyn! (now if 13d had been all people of the caliber and character of Recknor - I'd be voting for them. But...LOL...no way!) Glad he "caught" the Amarex errors. Up to this time we were told how wonderful Amarex is doing, and I suspect for quite a while Nader actually felt they were doing a good job. But it appears calling for an audit, etc. suggests he must have had some doubts as well.
It's very distressing the damage and delay Amarex has caused. Here's where our PR folks could be useful. I doubt Amarex wants this topic to be a BIG NEWS ITEM. If this "thing" was blown up a bit (look for huge settlements - just for the press attention), I would suspect Amarex would want a speedy conclusion to get its name out of the (opposite of "lime-lite"...Maybe) "crud-lite." Maybe time to use our new "resources" to "hold Amarex's feet to the fire!"
Linking Leronlimab with Anderson was a coup! It's a institution where getting some attention is very relevant.
Meanwhile, I was perusing the World-o-meter results. This virus is far from down and out! Of course the United States is winning in the stupid category. 1891 deaths two days ago now 1937 deaths, a comfortable lead in deaths - Great job FDA. But Brazil isn't out of the woods either with 451 deaths then yesterday 628 deaths. Hopefully we can help them cut the number dying in Brazil, as our FDA seems perverse to allowing Leronlimab to save lives in the US.
Oh well, it seems CytoDyn is going in the right direction. Hoping for more good news in the coming week.
Leronlimab is one amazing drug, with all of its applications and safety!
Glad I stumbled upon this company and especially Leronlimab - funny name but a very promising drug.
Take care!!
IMO
News 
Market Data 
Discover 
